5-(4-(5-Chloro-2-methylphenyl)piperazin-1-yl)-2-(4-methoxybenzamino)benzoic acid

ID: ALA5200143

Chembl Id: CHEMBL5200143

PubChem CID: 50782246

Max Phase: Preclinical

Molecular Formula: C26H26ClN3O4

Molecular Weight: 479.96

Names and Identifiers

Canonical SMILES:  COc1ccc(C(=O)Nc2ccc(N3CCN(c4cc(Cl)ccc4C)CC3)cc2C(=O)O)cc1

Standard InChI:  InChI=1S/C26H26ClN3O4/c1-17-3-6-19(27)15-24(17)30-13-11-29(12-14-30)20-7-10-23(22(16-20)26(32)33)28-25(31)18-4-8-21(34-2)9-5-18/h3-10,15-16H,11-14H2,1-2H3,(H,28,31)(H,32,33)

Standard InChI Key:  QFJLWZSHKPVZGX-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA5200143

   Fubp1-IN-2

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 479.96

Molecular Weight (Monoisotopic): 479.1612

AlogP: 4.93

#Rotatable Bonds: 6

Polar Surface Area: 82.11

Molecular Species: ACID

HBA: 5

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 7

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 4.23

CX Basic pKa: 2.28

CX LogP: 6.18

CX LogD: 3.16

Aromatic Rings: 3

Heavy Atoms: 34

QED Weighted: 0.52

Np Likeness Score: -1.39

References

1. Dobrovolskaite A, Moots H, Tantak MP, Shah K, Thomas J, Dinara S, Massaro C, Hershberger PM, Maloney PR, Peddibhotla S, Sugarman E, Litherland S, Arnoletti JP, Jha RK, Levens D, Phanstiel O..  (2022)  Discovery of Anthranilic Acid Derivatives as Difluoromethylornithine Adjunct Agents That Inhibit Far Upstream Element Binding Protein 1 (FUBP1) Function.,  65  (22.0): [PMID:36382923] [10.1021/acs.jmedchem.2c01350]

Source

Source(1):

• Scientific Literature